title: [Topic silver sulfadiazine bicytopenia: first case].
authors.affiliation: Service de Pharmacologie clinique et de Toxicologie, Centre Régional de Pharmacovigilance de Lorraine, CHU de Nancy, Nancy, France.
authors.forename: H
authors.initials: H
authors.lastname: Blangy
authors.forename: D
authors.initials: D
authors.lastname: Simon
authors.forename: A
authors.initials: A
authors.lastname: Lévy-Cloez
authors.forename: F
authors.initials: F
authors.lastname: Feillet
authors.forename: J P
authors.initials: JP
authors.lastname: Fyad
authors.forename: P
authors.initials: P
authors.lastname: Tréchot
authors.forename: P
authors.initials: P
authors.lastname: Gillet
authors.forename: P
authors.initials: P
authors.lastname: Lascombes
mesh_terms: D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D007223:Infant; D008297:Male; D009503:Neutropenia / Q000139:chemically induced* / Q000473:pathology*; D012837:Silver Sulfadiazine / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000891:Anti-Infective Agents, Local; D012837:Silver Sulfadiazine